1/299
Proverbs 16:3
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
D) Pharmaceutical care
It refers to the responsible provision of drug therapy to achieve definite outcomes that are intended to improve a patient's quality of life
A. Professional-patient's relationship
B. Therapeutic drug monitoring
C. Drug therapy assessment
D. Pharmaceutical care
E. Formal documentation
A) Cost-of-Illness Evaluation
It involves measuring direct and indirect costs attributable to a specific disease
A. Cost-of-Illness Evaluation
B. Cost-Effectiveness Analysis
C. Cost-Minimization Analysis
D. Cost-Utility Analysis
E. Cost-Benefit Analysis
D) Cost-Utility Analysis
The method that integrates the patient preferences and health-related quality of life
A. Cost-of-Illness Evaluation
B. Cost-Effectiveness Analysis
C. Cost-Minimization Analysis
D. Cost-Utility Analysis
E. Cost-Benefit Analysis
B) Cost-Effectiveness Analysis
A way of summarizing the health benefits and resources used by competing health care programs so that policy makers can choose among them
A. Cost-of-Illness Evaluation
B. Cost-Effectiveness Analysis
C. Cost-Minimization Analysis
D. Cost-Utility Analysis
E. Cost-Benefit Analysis
B) Quality of life
It refers to the value assigned to duration of life as modified by impairments, functional states, perceptions and social opportunities that are influenced by disease, injury, treatment or policy
A. Optimum health
B. Quality of life
C. Health outcomes
D. Responsiveness
E. Wellness of being
D) Blinded study
A study design in which neither the study subject nor the study staff is aware of which group or intervention the subjects has been assigned
A. Randomized control trial
B. Crossover study
C. Cohort study
D. Blinded study
E. Cross-sectional study
B) Case control study
A retrospective comparison of causal factors or exposures in a group of persons with disease and those of persons without the disease
A. Randomized control trial
B. Case control study
C. Cohort study
D. meta-analysis
E. open-label trial
D) Cohort study
A retrospective or prospective follow-up study of exposed and non-exposed defined groups in which a variable of interest is measured
A. Cross-sectional study
B. Case control study
C. Cross over study
D. Cohort study
E. open label trial
B) Cross over study
A trial comparing treatments in which participants, on completion of one treatment, are switched to the other
A. Cross-sectional study
B. Cross over study
C. meta-analysis
D. open label trial
E. cohort study
A) Cross-sectional study
A study that examines the presence or absence of a disease and other variable in a defined population and the potential risk factor at a particular point in time or time-interval
A. Cross-sectional study
B. Cohort study
C. case control study
D. cross over study
E. case series
D) those between 1 day and 1 month
Which of the following best describes the neonates?
A. those who are 1 month to 1 year of age
B. those who are 1 year to 12 years of age
C. those who are 12 to 16 years of age
D. those between 1 day and 1 month
E. those born before 32 weeks of gestational age
D) I, II and IV only
Characteristic gray color
Abdominal distention
Hypertension
Clinical manifestation of Gray Baby Syndrome include:
I. Characteristic gray color
II. Abdominal distention
III. Hypertension
IV. Progressive shock
A. I only
B. I and IV only
C. I, II and III only
D. I, II and IV only
E. I and III only
B) I, II and III only
Polyneuritis
Mental retardation
Limb deformities
Which of the following is associated with the use of thalidomide?
I. Polyneuritis
II. Mental retardation
III. Limb deformities
A. I only
B. I, II and III only
C. II and III only
D. III only
E. I and III only
D) I, II and IV only
Polypharmacy
Inappropriate prescribing
Multiple adherence
Factors that increase the risk of drug-related problems in the elderly include:
I. Polypharmacy
II. Inappropriate prescribing
III. Medication adherence
IV. Multiple diseases
A. I and II only
B. I, II and III only
C. II and IV only
D. I, II and IV only
E. I, II, III and IV
B) I, III and IV only
Impaired hearing
Multiple diseases and medication
Reliance on a caregiver for the history
Potential difficulties that may occur while taking medication histories from the elderly include:
I. Impaired hearing
II. Mental acuity
III. Multiple diseases and medication
IV. Reliance on a caregiver for the history
A. I, II and III only
B. I, III and IV only
C. II, III and IV only
D. I, II and IV only
E. I, II, III and IV
B) Pharmacovigilance
Refers to the continual monitoring for unwanted effects and other safety-related aspects of marketed drugs
A. Pharmacoepidemiology
B. Pharmacovigilance
C. Pharmacoinformatics
D. Pharmacogenetics
E. Pharmacogenomics
A) Pharmacoepidemiology
Study of the use of and effect of drugs in a large number of people
A. Pharmacoepidemiology
B. Pharmacovigilance
C. Pharmacoinformatics
D. Pharmacogenetics
E. Pharmacogenomics
D) Adverse drug reaction
Any noxious, unintended, and undesired effect of a drug that occurs at doses used in humans for prophylaxis, diagnosis or therapy
A. Adverse drug event
B. Allergy
C. Hypersensitivity
D. Adverse drug reaction
D) I and III only
Provides supplemental information to the physical examination and usually the first diagnostic test in a cardiac workup
Gives information about position and size of the heart and chambers and surrounding anatomy
Which of the following is/are true regarding chest x-ray?
I. Provides supplemental information to the physical examination and usually the first diagnostic test in a cardiac workup
II. Provides details of internal cardiac structures
III. Gives information about position and size of the heart and chambers and surrounding anatomy
A. I only
B. I, II and III
C. I and II only
D. I and III only
E. II and III only
E) IV only
The manifestation of chromium deficiency include:
I. Alopecia
II. Depigmentation of hair and skin
III. Red blood cell fragility
IV. Glucose intolerance
A. I and II only
B. II and IV only
C. I, II, III and VI
D. III only
E. IV only
E) I, II and III only
Poor wound healing
Poor growth
Poor resistance to infection
The manifestation of zinc deficiency include:
I. Poor wound healing
II. Poor growth
III. Poor resistance to infection
A. I only
B. II and III only
C. I and IV only
D. III only
E. I, II and III only
C) I, II and IV only
Nature of amino acid solution
pH
Electrolyte content
Incompatibilities with fat emulsions cause majority of formulation problems in TPN. Which of the following affects lipid stability in TPN preparations?
I. Nature of amino acid solution
II. pH
III. The amount of dissolved oxygen in the solution
IV. Electrolyte content
A. I, II and III only
B. II, III and IV only
C. I, II and IV only
D. I and II only
E. I and IV only
D) II, III and IV only
Presence of trace minerals
Amount of dissolved oxygen in the solution
pH
Ascorbic acid is the most rapidly oxidized vitamin. The rate of oxidation depends on:
I. Electrolyte content
II. Presence of trace minerals
III. Amount of dissolved oxygen in the solution
IV. pH
A. IV only
B. I and III only
C. I, II and III only
D. II, III and IV only
E. II and IV only
C) Thiamine
Which of the following is the most rapidly reduced vitamin?
A. Riboflavin
B. Niacin
C. Thiamine
D. Cevitamic Acid
E. Ascorbic Acid
E) I, II and III
Administration of albumin
Congestive heart failure
Cirrhosis
Which of the following are associated with delusional hyponatremia?
I. Administration of albumin
II. Congestive heart failure
III. Cirrhosis
A. II only
B. I and III only
C. I and II only
D. I only
E. I, II and III
B) I and III only
End product of protein metabolism
Filtered completely at golmerulus
Which of the following is/are true regarding blood urea nitrogen (BUN)?
I. End product of protein metabolism
II. Produces by liver and kidney
III. Filtered completely at glomerulus
A. I and II only
B. I and III only
C. II and III only
D. I, II and III
E. I only
D) I and II only
Not absorbed and secreted by the kidney
Filtered freely at the glomerulus
Which of the following accurately describes creatinine?
I. Not absorbed and secreted by the kidney
II. Filtered freely at the glomerulus
III. Metabolized by the kidney
A. I only
B. II only
C. III only
D. I and II only
E. II and III only